FilingSEC EDGAR424B3
Kazia Therapeutics Changes ADR Depositary to JPMorgan
· SEC accepted
StageCompleted
Filing content
Kazia Therapeutics has entered into a deposit agreement to appoint JPMorgan Chase Bank as the new depositary for its ADR program, replacing BNY Mellon.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…